~~<i id='C4960F1DD4'><strike id='C4960F1DD4'><tt id='C4960F1DD4'><pre id='C4960F1DD4'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：hotspot 2025-10-09 00:17:10 Page View：772

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New details revealed about Purdue's marketing of OxyContin
Next article： George Santos makes 1st court appearance after pleading not guilty to 13 counts

focus

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

As Maui death toll rises, number of missing remains unclear

3:12MembersoftheSearchandRecoveryTeam,accompaniedbycadaverdogs,checkareasdestroyedbywildfiresinLahai

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

Ukraine taking heavy casualties 10 weeks into its counteroffensive

3:16UkrainiansoldiersfireamortartowardsRussianpositionsatthefrontline,nearBakhmut,Donetskregion,Ukra